Research Article

Factors affecting muscle strength in cancer patients receiving chemotherapy

Jiro Nakano*, Shun Ishii, Takuya Fukushima, Ayumi Natsuzako, Junya Sakamoto and Minoru Okita

Published: 07/10/2017 | Volume 1 - Issue 2 | Pages: 056-066

ABSTRACT

This study aimed to investigate the relationship between muscle weakness and cancerrelated symptoms in patients undergoing chemotherapy for hematological malignancies and solid tumors. We recruited hospitalized patients older than 20 years who were receiving chemotherapy. Patients were divided into a solid tumor (n=74) and hematological malignancy (n=80) group.Age, body mass index (BMI), strength and thickness of the quadriceps femoris muscle, serum albumin and C-reactive protein levels, blood hemoglobin concentration, fatigue, psychological distress and pain, and duration of hospitalization were assessed. Eight physical symptoms (fatigue, nausea and vomiting, pain, dyspnea, insomnia, appetite loss, constipation, and diarrhea) were also evaluated. Correlation and multiple regression analyses were conducted to identify factors affecting muscle strength in each group. Muscle strength was associated with fatigue in the solid tumor group and with age, BMI, muscle thickness, albumin and hemoglobin in the hematological malignancy group. Therefore, factors contributing to muscle strength might differ between patients with solid tumors and those with hematological malignancies. In particular, fatigue was an important factor in patients with solid tumors, while anemia was an important factor in patients with hematological malignancies. We therefore suggest that different treatments for muscle weakness might be considered for patients with these cancer types.

Read Full Article HTMLDOI: 10.29328/journal.jnpr.1001008Cite this Article

REFERENCES

  1. Stephens NA, Gray C, MacDonald AJ, Tan BH, Gallagher IJ, et al. Sexual dimorphism modulates the impact of cancer cachexia on lower limb muscle mass and function. Clin Nutr. 2012; 31: 499-505. Ref.: https://goo.gl/rjsncd
  2. Argiles JM, Busquets S, Felipe A, Lopez-Soriano FJ. Muscle wasting in cancer and ageing: cachexia versus sarcopenia. Adv Gerontol. 2006; 18: 39-54. Ref.: https://goo.gl/fX8mEc
  3. Toth MJ, Callahan DM, Miller MS, Tourville TW, Hackett SB, et al. Skeletal muscle fiber size and fiber type distribution in human cancer: Effects of weight loss and relationship to physical function. Clin Nutr. 2016; 35: 1359-1365. Ref.: https://goo.gl/Xbhqw7
  4. Tisdale MJ. Mechanisms of cancer cachexia. Physiol Rev. 2009; 89: 381-410. Ref.: https://goo.gl/JgiKgB
  5. Bongaerts GP, van Halteren HK, Verhagen CA, Wagener DJ. Cancer cachexia demonstrates the energetic impact of gluconeogenesis in human metabolism. Med Hypotheses. 2006; 67: 1213-1222. Ref.: https://goo.gl/46H3YQ
  6. Argiles JM, Busquets S, Stemmler B, Lopez-Soriano FJ. Cancer cachexia: understanding the molecular basis. Nat Rev Cancer. 2014; 14: 754-762. Ref.: https://goo.gl/2QJWF9
  7. Kilgour RD, Vigano A, Trutschnigg B, Hornby L, Lucar E, et al. Cancer-related fatigue: the impact of skeletal muscle mass and strength in patients with advanced cancer. J Cachexia Sarcopenia Muscle. 2011; 1: 177-185. Ref.: https://goo.gl/Gzo5zX
  8. Yennurajalingam S, Palmer JL, Zhang T, Poulter V, Bruera E. Association between fatigue and other cancer-related symptoms in patients with advanced cancer. Support Care Cancer. 2008; 16: 1125-1130. Ref.: https://goo.gl/bVUaXg
  9. Berglund G, Bolund C, Fornander T, Rutqvist LE, Sjoden PO. Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients. Eur J Cancer. 1991; 27: 1075-1081. Ref.: https://goo.gl/4Y1Jrn
  10. Lee D, Hwang JH, Chu I, Chang HJ, Shim YH, et al. Analysis of factors related to arm weakness in patients with breast cancer-related lymphedema. Support Care Cancer. 2015; 23: 2297-2304. Ref.: https://goo.gl/tJmRuU
  11. Kawahara K, Suzuki T, Yasaka T, Nagata H, Okamoto Y, et al. Evaluation of the site specificity of acute disuse muscle atrophy developed during a relatively short period in critically ill patients according to the activities of daily living level: A prospective observational study. Aust Crit Care. 2017; 30: 29-36. Ref.: https://goo.gl/uorwVX
  12. Ludwig H, Van Belle S, Barrett-Lee P, Birgegard G, Bokemeyer C, et al. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer. 2004; 40: 2293-2306. Ref.: https://goo.gl/KVMrT8
  13. Birgegard G, Gascon P, Ludwig H. Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of the European CANCER ANAEMIA SURVEY. Eur J Haematol. 2006; 77: 378-386. Ref.: https://goo.gl/HxtQmR
  14. Penninx BW, Pahor M, Cesari M, Corsi AM, Woodman RC, et al. Anemia is associated with disability and decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc. 2004; 52: 719-724. Ref.: https://goo.gl/bjvLnR
  15. Tah PC, Nik Shanita S, Poh BK. Nutritional status among pediatric cancer patients: a comparison between hematological malignancies and solid tumors. J Spec Pediatr Nurs. 2012; 17: 301-311. Ref.: https://goo.gl/ZdaJU7
  16. Argiles JM, Busquets S, Garcia-Martinez C, Lopez-Soriano FJ. Mediators involved in the cancer anorexia-cachexia syndrome: past, present, and future. Nutrition. 2005; 21: 977-985. Ref.: https://goo.gl/eCS5bE
  17. Gilliam LA, St Clair DK. Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress. Antioxid Redox Signal. 2011; 15: 2543-2563. Ref.: https://goo.gl/oofZG9
  18. Steinbacher P, Eckl P. Impact of oxidative stress on exercising skeletal muscle. Biomolecules. 2015; 5: 356-377. Ref.: https://goo.gl/BVEjcz
  19. Brown DJ, McMillan DC, Milroy R. The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer. Cancer. 2005; 103: 377-382. Ref.: https://goo.gl/rXCwn4
  20. Brunello A, Kapoor R, Extermann M. Hyperglycemia during chemotherapy for hematologic and solid tumors is correlated with increased toxicity. Am J Clin Oncol. 2011; 34: 292-296. Ref.: https://goo.gl/Adq1Qp
  21. Katoh M, Kaneko Y. An Investigation into Reliability of Knee Extension Muscle Strength Measurements, and into the Relationship between Muscle Strength and Means of Independent Mobility in the Ward: Examinations of Patients Who Underwent Femoral Neck Fracture Surgery. JPhys Ther Sci. 2014; 26: 15-19. Ref.: https://goo.gl/VogqKn
  22. Tillquist M, Kutsogiannis DJ, Wischmeyer PE, Kummerlen C, Leung R, et al. Bedside ultrasound is a practical and reliable measurement tool for assessing quadriceps muscle layer thickness. JPEN J Parenter Enteral Nutr. 2013; 38: 886-890. Ref.: https://goo.gl/zG3Wyu
  23. Wu YY, Chao TY, Liu HY, Huang TC, Chen JH, et al. The correlation between a chronic inflammatory marker Tartrate-resistant acid phosphatase 5a with cancer cachexia. J BUON. 2015; 20: 325-331. Ref.: https://goo.gl/RrHHvk
  24. Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood. 2006; 107: 1747-1750. Ref.: https://goo.gl/FWrs1z
  25. Kuzuya M, Izawa S, Enoki H, Okada K, Iguchi A. Is serum albumin a good marker for malnutrition in the physically impaired elderly? Clin Nutr. 2007; 26: 84-90. Ref.: https://goo.gl/AFzBEu
  26. Pires Corona L, Drumond Andrade FC, de Oliveira Duarte YA, Lebrao ML. The Relationship between Anemia, Hemoglobin Concentration and Frailty in Brazilian Older Adults. J Nutr Health Aging. 2015; 19: 935-940. Ref.: https://goo.gl/qNTSaz
  27. Okuyama T, Akechi T, Kugaya A, Okamura H, Shima Y, et al. Development and validation of the cancer fatigue scale: a brief, three-dimensional, self-rating scale for assessment of fatigue in cancer patients. J Pain Symptom Manage. 2000; 19: 5-14. Ref.: https://goo.gl/6dww2M
  28. Kroz M, Zerm R, Reif M, HB VONL, Schad F, et al. Validation of the German version of the Cancer Fatigue Scale (CFS-D). Eur J Cancer Care (Engl). 2008; 17: 33-41. Ref.: https://goo.gl/YVXvZ4
  29. Lasheen W, Walsh D, Sarhill N, Davis M. Intermittent cancer pain: clinical importance and an updated cancer pain classification. Am J Hosp Palliat Care. 2010; 27: 182-186. Ref.: https://goo.gl/3kyE71
  30. Vodermaier A, Millman RD. Accuracy of the Hospital Anxiety and Depression Scale as a screening tool in cancer patients: a systematic review and meta-analysis. Support Care Cancer. 2011; 19: 1899-1908. Ref.: https://goo.gl/tvges4
  31. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67: 361-370. Ref.: https://goo.gl/5kkgKr
  32. Kugaya A, Akechi T, Okuyama T, Okamura H, Uchitomi Y. Screening for psychological distress in Japanese cancer patients. Jpn J Clin Oncol. 1998; 28: 333-338. Ref.: https://goo.gl/gQ7CGX
  33. Tan CS, Read JA, Phan VH, Beale PJ, Peat JK, et al. The relationship between nutritional status, inflammatory markers and survival in patients with advanced cancer: a prospective cohort study. Support Care Cancer. 2014; 23: 385-391. Ref.: https://goo.gl/euXKgM
  34. Maughan RJ, Watson JS, Weir J. Strength and cross-sectional area of human skeletal muscle. J Physiol. 1983; 338: 37-49. Ref.: https://goo.gl/pEZfPK
  35. Hayashida I, Tanimoto Y, Takahashi Y, Kusabiraki T, Tamaki J. Correlation between muscle strength and muscle mass, and their association with walking speed, in community-dwelling elderly Japanese individuals. PLoS One. 2014; 9: e111810. Ref.: https://goo.gl/VZfrKM
  36. Ryan AM, Power DG, Daly L, Cushen SJ, Ni Bhuachalla E, et al. Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later. Proc Nutr Soc. 2016; 75: 199-211. Ref.: https://goo.gl/QWjuRT
  37. Tanne Z, Coleman R, Nahir M, Shomrat D, Finberg JP, et al. Ultrastructural and cytochemical changes in the heart of iron-deficient rats. Biochem Pharmacol. 1994; 47: 1759-1766. Ref.: https://goo.gl/kWfXkY
  38. McNabney LA, Essig DA. 5'-Aminolevulinate synthase activity is decreased in skeletal muscle of anemic rats. Am J Physiol. 1992; 263: C429-435. Ref.: https://goo.gl/nQU3bP
  39. Antunes D, Padrao AI, Maciel E, Santinha D, Oliveira P, et al. Molecular insights into mitochondrial dysfunction in cancer-related muscle wasting. Biochim Biophys Acta. 2014; 1841: 896-905. Ref.: https://goo.gl/AF9wg5
  40. Molica S, Mirabelli R, Molica M, Levato L, Mauro FR, et al. Clinical relevance and treatment of nonautoimmune anemia in chronic lymphocytic leukemia. Cancer Manag Res. 2011; 3: 211-217. Ref.: https://goo.gl/dwhQRz
  41. Smith MA, Shah NR, Lobel JS, Cera PJ, Gary GW, et al. Severe anemia caused by human parvovirus in a leukemia patient on maintenance chemotherapy. Clin Pediatr (Phila). 1988; 27: 383-386. Ref.: https://goo.gl/rPwSjU
  42. Visovsky C. Muscle strength, body composition, and physical activity in women receiving chemotherapy for breast cancer. Integr Cancer Ther. 2006; 5: 183-191. Ref.: https://goo.gl/7U4WiZ
  43. Chen HM, Tsai CM, Wu YC, Lin KC, Lin CC. Randomised controlled trial on the effectiveness of home-based walking exercise on anxiety, depression and cancer-related symptoms in patients with lung cancer. Br J Cancer. 2014; 112: 438-445. Ref.: https://goo.gl/xj68Sd
  44. Bouaziz W, Vogel T, Schmitt E, Kaltenbach G, Geny B, Lang PO. Health benefits of aerobic training programs in adults aged 70 or over: A systematic review. Presse Med. 2017 46:794-807 Ref.: https://goo.gl/PvqE8a
  45. Willis WT, Brooks GA, Henderson SA, Dallman PR. Effects of iron deficiency and training on mitochondrial enzymes in skeletal muscle. J Appl Physiol(1985). 1987; 62: 2442-2446. Ref.: https://goo.gl/zLHkti